Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1994 Nov;53(11):782–783. doi: 10.1136/ard.53.11.782-b

Rheumatoid arthritis in black Americans.

J M Anaya, D Rosler, L R Espinoza
PMCID: PMC1005467  PMID: 7826145

Full text

PDF
782

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón G. S., Acton R. T., Koopman W. J., Barger B. O. CREG antigens differentially influence expression of extraarticular manifestations in whites and blacks with rheumatoid arthritis. Semin Arthritis Rheum. 1983 Nov;13(2):169–173. doi: 10.1016/0049-0172(83)90003-3. [DOI] [PubMed] [Google Scholar]
  2. Alarcón G. S., Tracy I. C., Blackburn W. D., Jr Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum. 1989 Jun;32(6):671–676. doi: 10.1002/anr.1780320603. [DOI] [PubMed] [Google Scholar]
  3. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  4. Drosos A. A., Lanchbury J. S., Panayi G. S., Moutsopoulos H. M. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum. 1992 Jul;35(7):745–748. doi: 10.1002/art.1780350705. [DOI] [PubMed] [Google Scholar]
  5. Felson D. T., Anderson J. J., Boers M., Bombardier C., Chernoff M., Fried B., Furst D., Goldsmith C., Kieszak S., Lightfoot R. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993 Jun;36(6):729–740. doi: 10.1002/art.1780360601. [DOI] [PubMed] [Google Scholar]
  6. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  7. Furst D. E. Predictors of worsening clinical variables and outcomes in rheumatoid arthritis. Rheum Dis Clin North Am. 1994 May;20(2):309–319. [PubMed] [Google Scholar]
  8. López-Méndez A., Paul W. A., Alarcón G. S. Rheumatoid arthritis in American blacks: a clinical and radiological study. J Rheumatol. 1989 Sep;16(9):1197–1200. [PubMed] [Google Scholar]
  9. MacGregor A. J., Riste L. K., Hazes J. M., Silman A. J. Low prevalence of rheumatoid arthritis in black-Caribbeans compared with whites in inner city Manchester. Ann Rheum Dis. 1994 May;53(5):293–297. doi: 10.1136/ard.53.5.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McKendry R. J., Dale P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol. 1993 Nov;20(11):1850–1856. [PubMed] [Google Scholar]
  11. Pincus T., Callahan L. F. Quantitative measures to assess, monitor and predict morbidity and mortality in rheumatoid arthritis. Baillieres Clin Rheumatol. 1992 Feb;6(1):161–191. doi: 10.1016/s0950-3579(05)80343-7. [DOI] [PubMed] [Google Scholar]
  12. Ward M. M., Leigh J. P., Fries J. F. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Arch Intern Med. 1993 Oct 11;153(19):2229–2237. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES